0001104659-25-009279 Sample Contracts
WARRANT AGENCY AGREEMENTWarrant Agency Agreement • February 5th, 2025 • Annovis Bio, Inc. • Pharmaceutical preparations
WARRANT AGENCY AGREEMENT (this “Warrant Agreement”) dated as of February 4, 2025 (the “Issuance Date”) between Annovis Bio., Inc., a company incorporated under the laws of the State of Delaware (the “Company”), and Equiniti Trust Company, LLC (the “Warrant Agent”).
UNDERWRITING AGREEMENT between Annovis Bio, Inc. and ThinkEquitY LLC as Representative of the Several Underwriters ANNOVIS BIO, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 5th, 2025 • Annovis Bio, Inc. • Pharmaceutical preparations • New York
As Representative of the several Underwriters named on Schedule 1 attached hereto 17 State Street, 41st Floor New York, New York 10004
COMMON STOCK PURCHASE WARRANT ANNOVIS BIO, INC.Common Stock Purchase Warrant • February 5th, 2025 • Annovis Bio, Inc. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, _________________. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 4, 2025 (the “Initial Exercise Date”) and prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Annovis Bio, Inc., a Delaware corporation (the “Company”), up to _____________ Common Shares (as defined below) of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The Warrant shall initially be issued and maintained in the form of a security held in book entry form at the offices of the Warrant Agent (as defined below) , subject to a